ASCO

Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.

[ASCO @ASCO]

#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!

[ASCO @ASCO]

Deadline: Dec. 1, 2026! Last call for oncology professionals in Africa to apply for the ASCO and @AORTIC_AFRICA ICRS program. 1-year hybrid research training + mentorship to advance cancer care in your community.

Apply today. https://t.co/gCtYL26q9y
#ASCOGlobalImpact

[ASCO @ASCO]

We are proud to be a Cooperating Partner for the 20th @SG_BCC in Vienna, Austria, March 17–20, 2027.

Join global leaders examining the latest evidence in early breast cancer care. Register today: https://t.co/zM63tGI2Az
#SGBCC2027

[ASCO @ASCO]

Voting in the ASCO Election is open now until December 2! Meet the candidates for the Board of Directors – Designated Community Oncologist seat. Learn more about each candidate and make your voice heard: https://t.co/CeWxD9mvWv

[ASCO @ASCO]

Our draft guideline recommendations for “Treatment of Locally Advanced Gastric Cancer” are now open for public comment.

Submit your comments to us by November 23: https://t.co/4RkUIZgFZ8

[ASCO @ASCO]

Hope to see you for a third year at #GU27, @abbylgrier! Register early and save through December 16: https://t.co/so4ISwv3pH

[Abby Grier @abbylgrier]

Great to be back at ASCO #GU26 for my second year! A whirlwind week of learning and catching up with collaborators and friends. Incredibly grateful for my mentors, who inspire me and made this possible. @JasonBrownMDPhD @PBarataMD @AJangMD @CParkMD @TanyaJindal97 @JeffreyYZhong

[Yale Cancer Center @YaleCancer]

.@CliffordHudis discusses the positive impact #AI will continue to have on patient outcomes, scientific advances, and the medical profession in the coming years at the @BioCT_org Future of Oncology Summit. @ASCO @SmilowCancer

[ASCO @ASCO]

Be discovered on the world’s largest stage for cancer research.

Submit your abstract to #ASCO27 to showcase your expertise, connect with leading oncology professionals, and help shape the future of cancer care: https://t.co/ckvUp08E4V

[ASCO @ASCO]

Our draft guideline recommendations for “Management of Immune-Related Adverse Events- neurologic, and dermatologic toxicities, and adverse events from steroids recommendations” are now open for public comment.

Submit your comments to us by November 20: https://t.co/mRpSqRTr5S

[ASCO @ASCO]

Final rules for Medicare reimbursement in 2027 implement a 2% cut to physician payments & changes to reimbursement for hospital outpatient services.

We’re assessing the full impact on cancer care, but our initial analysis is out: https://t.co/1gmIbiw6N8
#ASCOAdvocacy

[ASCO @ASCO]

🎙 @montypal of @cityofhope and @MarcoRuella of @PennMedicine break down landmark 10-year tisa-cel data in B-cell lymphomas, next-gen dual-targeted CARs, and the shift into earlier lines of treatment on a new episode of the #ASCODailyNews Podcast: https://t.co/TCP0E9bF6O

[ASCO @ASCO]

New #BreastCancer research funding is open from @ConquerCancerFd! Whether you're launching an independent lab, leading original trials, or mentoring future leaders, 3 new global grants are accepting submissions.

🌍 U.S. & Global applicants welcome: https://t.co/n0avidbLwa

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Great perspective from @PauloBergerot in @ASCO Daily News on a critical challenge in #ExerciseOncology: moving beyond the optimal exercise dose to interventions that are feasible, accessible, and sustainable in patients’ everyday lives #ASCOQLTY26

https://t.co/qPbCLDvb75

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

That time of year is here again! ⏰ How did it come around so fast? 😅 @ASCO

Time to start preparing those abstracts for #ASCO27!

📍 Chicago | June 4–8, 2027
📝 Abstract deadline: January 26, 2027

Looking forward to another exciting year of science, innovation & collaboration!

[ASCO @ASCO]

Time is running out to share your story on the #ASCO27 stage! How did a patient’s journey look before your team stepped in & what changed after you collaborated? Inspire others by sharing your perspective on teamwork.

Audition for ASCO Voices by Nov 13: https://t.co/MB5rBaNJrn

[ASCO @ASCO]

Last week, we released a new Living Guideline for treating HR+, HER2-negative stage I-III #breastcancer, with recommendations for individualized care based on genomics, patient preferences, and estimated risk. Read a brief analysis from #ASCODailyNews: https://t.co/BCKVsbxfGT

[ASCO @ASCO]

Join colleagues across specialties at the 2027 Multidisciplinary Head and Neck Cancers Symposium in Orlando from Feb. 25-27! We are a proud co-sponsor of this meeting w/ @ASTRO_org.

Register by Jan. 15 for the best rates: https://t.co/AyVYQ073p0
#MHNCS27

[ASCO @ASCO]

Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today!

Due Dec. 10th: https://t.co/ZXReekSoPL

[ASCO @ASCO]

Tell us who inspires you! The @ConquerCancerFd Women Who Conquer Cancer Mentorship Award deadline is approaching. Recognize a woman leader who has made an outstanding commitment to mentoring. Nominate today!

Due Dec. 10th: https://t.co/ZXReekSoPL

[ASCO @ASCO]

TIME IS RUNNING OUT! 🚨

Proposals for ASCO's 2027 International Palliative Care Education Collaboration must be submitted by November 30, 2026. Don't miss this multi-year opportunity to empower local palliative care champions.

Apply: https://t.co/oAufCVeZFA
#ASCOGlobalImpact

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Want to learn more about the science presented at #ASCOQLTY26 ? 🎧 Highly recommend this @ASCO podcast with @MontyPal and @RyanNipp!

Especially loved their discussion of @PauloBergerot’s study (Abstract 487) showing how remote exercise improves QoL, with fatigue reduction as a key mechanism

https://t.co/trT2gSg8Xv